MMJ Recs

JULY 11, 2024

Behavioral Insomnia of Childhood : This type occurs in children and can be divided into two categories: Sleep-Onset Association Type : The child depends on specific conditions or associations (like being rocked or having a parent present) to fall asleep. excessive noise or light), can also disrupt the natural sleep-wake cycle.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

OCTOBER 1, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, today announced that Chairman and CEO Anthony P. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials Chronic Pain 40

CannaTech

SEPTEMBER 16, 2018

Similar frameworks exist across the world, presenting the same set of challenges Canada has faced along the way. But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression.

Education 66

Education Medicine Clinical Trials Patients 66

MMJ Recs

NOVEMBER 20, 2023

Therapeutic Effects of Cannabinoids Pain Relief: Perhaps one of the most recognized therapeutic effects of cannabinoids is pain relief. Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. As such, patients report reduced reliance on opioids and other pain medications, which often come with severe side effects.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

SpeedWeed

AUGUST 4, 2021

After watching my brother self-medicate for his chronic pain for decades, I didn’t understand how cannabis was important to him as a medicine. I always thought he used his chronic pain as an “excuse” to self-administer what I thought was a toxic drug. . in 2014, I watched my brother walk into a cannabis clinic.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

OCTOBER 5, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it will present at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on Thursday, October 7, 2021. The Company’s presentation will be available for viewing that day at 10:10 a.m.

Pharmaceutical 40

Pharmaceutical Clinical Trials Chronic Pain Media 40

Cannabis Law Report

OCTOBER 19, 2021

Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that it will present at the Dawson James Securities 6th Annual Small Cap Growth Conference on Thursday, October 21, 2021, at 4:30 p.m. ET in Track 1. MyMD Chief Scientific Officer Adam Kaplin, M.D.,

Pharmaceutical 40

Pharmaceutical Therapy Clinical Trials Chronic Pain 40

CannaMD

NOVEMBER 8, 2019

As with all clinical information, this is part of the confidential medical record and protected under patient privacy and confidentiality laws and regulations. At present, most products containing THC, CBD, or other cannabinoids are not approved for this purpose by the FDA. VA clinicians may not recommend medical marijuana.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Cannabis Law Report

SEPTEMBER 22, 2021

New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. “We

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

Cannabis Law Report

DECEMBER 1, 2021

Format: Presentation and 1×1 meetings (virtual). Presentation time: Wednesday, December 8 at 4:00 p.m. The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. Date: December 2, 2021. Format: 1-on-1 meetings (virtual).

Pharmaceutical 40

Pharmaceutical Clinical Trials Chronic Pain Therapy 40

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

MMJ Recs

JULY 5, 2024

It is one of over 100 cannabinoids present in cannabis, and it is responsible for the “high” or euphoric sensation typically associated with cannabis use. Understanding THC’s mechanisms and clinical implications is crucial as researchers continue to uncover its therapeutic potential and limitations in medical settings.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

Cannabis Law Report

MARCH 17, 2022

CBD, short for cannabidiol, has become incredibly popular because of its potential to mitigate chronic pain, nausea, and even PTSD. It is an effective treatment for various health conditions such as chronic pain, nausea, seizures, and more. The CBD in the hemp plant is present in the seeds, stalks, flowers, and stems.

Oil 52

Oil CBD Chronic Pain Extraction 52

The Cannigma

JUNE 24, 2021

Meditation can also help people focus themselves on the here and now, away from anxieties about the present and regrets of the past. Both THC and CBD rich products may help those suffering from pain lasting several months.

CBD 101

CBD Microdosing Edibles Sleep 101

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

OCTOBER 26, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Dr. Chapman is a seasoned executive and global medical expert with extensive experience in designing and clinical trial protocols and conducting clinical trials.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

The Joint Blog

FEBRUARY 1, 2022

Multiple studies and clinical trials have shown that cannabidiol might help manage both acute and chronic pain. Presenting proof that you’re officially on medical marijuana prescription can help you pass through many cannabis-focused screenings. If you can, procure some proof of medical marijuana use.

CBD 52

CBD Sleep Clinical Trials Chronic Pain 52

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. One significant factor is the recognition of the opioid crisis and the need for alternative pain management strategies.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Gudin, MD, Chief Medical Officer of Virpax, presented a poster on Leucine Enkephalin as a potential analgesic at PainWeek 2021 in Las Vegas, Nevada.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

JUNE 11, 2019

Poirier sued following a surgical procedure that left her with chronic pain and limitations affecting her lifestyle and career. Following the incident, Poirier was prescribed numerous medications, but at the time of trial, she was only taking a muscle relaxant and cannabis. Robichaud 4. Siegrist with approval. ” 42.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development 52

Research and Development Medicine Access Media 52

FloridaMarijuana.net

JUNE 13, 2018

As the skin absorbs the pain-relieving compounds, the pain is blocked, but without affecting other parts of your body. Often, skin cancer or dermatological patients benefit from this method, however those with chronic pain and inflammation may benefit as well.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

NewsMunchies

AUGUST 25, 2021

Chronic pain represents an emerging public health issue. It is a way of life for those suffering with debilitating medical conditions that bring about widespread body aches, joint pain, and muscle tension. On the pain scale, I’d rank it somewhere between almost screaming and needing to be sedated.

CBD 98

CBD Chronic Pain Clinical Trials Oil 98

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials.

Research and Development 119

Research and Development Education Agriculture Patients 119

Healer

MARCH 26, 2021

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

The Cannigma

FEBRUARY 11, 2021

And I had been a serious chronic pain patient, plus some other issues after having spinal meningitis back in 1996. And um, I had gotten off of all of them because they don’t really help with chronic pain, they’re good for acute. So I had been on over 26 pharmaceuticals, including fentanyl, um, and, you name it.

Wellness and Beauty 141

Wellness and Beauty Data Patients Medicine 141

Veriheal

AUGUST 11, 2020

On the 17 th of July this year, a new study provides results which display cannabis as a safe and effective treatment for those with chronic pain from sickle cell disease. Gupta and Abrams’ study was conducted as a double-blind, placebo-controlled, randomized trial.

Treatment 59

Treatment Chronic Pain Clinical Trials Patients 59

Veriheal

JULY 12, 2021

A 2020 study reported that the top conditions reported amongst veterans include chronic pain , sleep problems , anxiety , and depression. They found that the participants who did not medicate with cannabis were more likely to present with severe depression as well as suicidal thoughts, more so than those who did medicate with cannabis.

Treatment 105

Treatment Sleep Clinical Trials Data 105

Cannabis Law Report

JULY 24, 2019

Examples of claims observed on your website and social media accounts in April 2019 that establish the intended use of your products as drugs include, but may not be limited to, the following: On your product webpage for CBD Disposable Vape Pen (Relieve): • “[F]or chronic pain.”. Chronic or arthritic pain.”. Chronic pain.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

MAY 14, 2022

However, observational studies have their limitations, which is why most have recently welcomed with open arms the UK Health Research Authority approved trial, Canpain. Canpain is planned to run for three years and aims to conduct clinical trials involving up to 5,000 patients suffering from chronic pain.

Access 52

Access CBD Research and Development Medicine 52

Weedistry

JANUARY 28, 2019

It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring. Something needs to be done”: Making medicine attainable and affordable.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. CB2 receptors are present in progenitor (“stem”) cells and are instrumental in driving neurogenesis (the creation of new brain cells).

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

AUGUST 30, 2019

Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis. The measure was the first expansion of Iowa’s medical cannabis program since Governor Kim Reynolds (R) vetoed a proposed expansion earlier this year. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed Assembly Bill 420 , which authorizes the University of California’s Center for Medicinal Cannabis Research to cultivate cannabis for clinical trials. Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy.

Legislation 45

Legislation Patients Access Banking 45

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law 40

Law Seed-To-Sale Hemp Recreational 40